KAM
EGRX
Krensavage Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-112,666
| Closed | -$1.78M | – | 16 |
|
|
2023
Q3 | $1.78M | Sell |
112,666
-771
| -0.7% | -$12.2K | 0.65% | 10 |
|
|
2023
Q2 | $2.21M | Sell |
113,437
-300
| -0.3% | -$5.83K | 0.7% | 12 |
|
|
2023
Q1 | $3.23M | Sell |
113,737
-1,088
| -0.9% | -$30.9K | 0.98% | 10 |
|
|
2022
Q4 | $3.36M | Sell |
114,825
-6,258
| -5% | -$183K | 1.04% | 10 |
|
|
2022
Q3 | $3.2M | Buy |
121,083
+69
| +0.1% | +$1.82K | 1.02% | 12 |
|
|
2022
Q2 | $5.38M | Buy |
121,014
+6,227
| +5% | +$277K | 1.78% | 11 |
|
|
2022
Q1 | $5.68M | Buy |
114,787
+8,300
| +8% | +$411K | 1.96% | 9 |
|
|
2021
Q4 | $5.42M | Sell |
106,487
-1,286
| -1% | -$65.5K | 1.88% | 9 |
|
|
2021
Q3 | $6.01M | Buy |
107,773
+36,969
| +52% | +$2.06M | 1.89% | 10 |
|
|
2021
Q2 | $3.03M | Buy |
+70,804
| New | +$3.03M | 1.03% | 10 |
|